These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 26228191

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.
    Reach I, Luong N, Chastang C, Chakroun M, Mirshahi S, Mirshahi MC, Soria J, Desmichels D, Baumelou A.
    Artif Organs; 2001 Jul; 25(7):591-5. PubMed ID: 11493282
    [Abstract] [Full Text] [Related]

  • 5. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD, Brandenburg VM, Lanzmich R, Floege J.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1552-8. PubMed ID: 15034159
    [Abstract] [Full Text] [Related]

  • 6. Dalteparin dosing in high-flux haemodialysis and haemodiafiltration.
    Sridharan S, Berdeprado J, Sivalingam M, Farrington K.
    Nephron Clin Pract; 2012 Jun; 122(1-2):53-7. PubMed ID: 23548465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism).
    Collignon F, Frydman A, Caplain H, Ozoux ML, Le Roux Y, Bouthier J, Thébault JJ.
    Thromb Haemost; 1995 Apr; 73(4):630-40. PubMed ID: 7495071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.
    Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Brosstad F.
    Nephrol Dial Transplant; 2001 May; 16(5):987-93. PubMed ID: 11328905
    [Abstract] [Full Text] [Related]

  • 12. Practical Value of Anti-Xa Activity in the Evaluation of Extracorporeal Circuit Anticoagulation during Haemodialysis: Results of a Cross-Sectional Single-Centre Study.
    Coene KLM, Dekker MJE, Kerskes MCHM, Hengst M, Schonck MJM, Konings CJAM, Scharnhorst V.
    Nephron; 2017 May; 137(3):205-211. PubMed ID: 28817831
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of dalteparin during haemodialysis.
    Nigten J, de Groot KA, Grootendorst DC, Koolen SL, Herruer MH, Schut NH.
    Nephron Clin Pract; 2013 May; 124(3-4):179-83. PubMed ID: 24401673
    [Abstract] [Full Text] [Related]

  • 14. Dalteparin anticoagulation in paediatric home haemodialysis.
    Lutkin M, Stronach L, Yadav P, Hothi DK.
    Pediatr Nephrol; 2018 Dec; 33(12):2337-2341. PubMed ID: 30173320
    [Abstract] [Full Text] [Related]

  • 15. A single dose of dalteparin effectively prevents clotting during haemodialysis.
    Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Fauchald P, Brosstad F.
    Nephrol Dial Transplant; 1999 Aug; 14(8):1943-7. PubMed ID: 10462275
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S, Barbano B, Cianci R, Gigante A, Di Donato D, Asllanaj B, Dimko M, Mariotti A, Morabito S, Pugliese F.
    G Ital Nefrol; 2010 Aug; 27(6):649-54. PubMed ID: 21132647
    [Abstract] [Full Text] [Related]

  • 19. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.
    de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF.
    Crit Care Med; 2000 Feb; 28(2):421-5. PubMed ID: 10708177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.